List view / Grid view

Hit-to-Lead

 

article

Rapidly transitioning from in silico hits to leads on ‘undruggable’ pain targets

13 December 2022 | By ,

Opioid addiction is an ongoing crisis in the US. Researchers have identified a key regulator that shapes analgesic and aversive outputs of kappa opioid receptor signalling, finding lead inhibitors of this previously ‘undruggable’ target class – the Regulators of G protein Signalling (RGS proteins) – to help re-establish non-addictive kappa…

article

Drug Target Review – Issue 4 2022

6 December 2022 | By

A new Drug Target Review issue is now ready to download! This issue features articles which explore how artificial intelligence can enhance screening and ways to find new hits through simultaneous orthogonal screens. Also included are articles on CRISPR, immuno-oncology and RSV vaccines.